calcium kidney stones - A New Gout Drug. Febuxostat wins marketing approval in the European Union
Treat Gout
 

A New Gout Drug. Febuxostat wins marketing approval in the European Union

It has taken a very long time for a major new gout drug to be developed and approved. Probably the best gout news in over 40 years, is that Febuxostat, which has been given the trade/brand name of Adenuric, has been approved by the European Medicines Agency for marketing in European Union (EU) countries.

Approval in one country does not mean approval in another, but the fact that the European Medicines Agency has approved it will carry weight when the medical authorities in other countries consider its approval.


60-Day Risk FREE Trial

People Said About Goutezol Gout Treatment
"My big toe was in horrible pain, so i went to emergency room. Dr diagnosed gout in my foot and gave me pain killers. I did some googling and found goutezol. I like that it's natural with no chemicals in it. Ive been taking it for about 6 months and so far no attack, and my doc confirmed lower uric acid in my blood. thank you!" Jeff, NY
gout treatment


  Generally, Febuxostat has been more effective when UA levels are below 0 mg/dL (595 mmol/??mol). However, even if they have been above this level, it has reduced UA levels down to the target in about 40% of study patients at an 80 mg dosage, and by more at higher dosages. We have also translated parts of this composition into French and Spanish to facilitate easier understanding of calcium kidney stones. In this way, more people will get to understand the composition.

BENEFITS In large trials Febuxostat (Adenuric) has outperformed Allopurinol, the most common gout medication for long term treatment. Like Allopurinol, it works to lower uric acid production by inhibiting xanthine oxidase, an enzyme required to produce uric acid. In two major studies it reduced uric acid (UA) in more gout sufferers, and more patients reached the target 0 mg/dL level more quickly, than did those on Allopurinol. Dwelving into the interiors of calcium kidney stones has led us to all this information here on calcium kidney stones. calcium kidney stones do indeed have a lot to tell!Dwelving into the interiors of calcium kidney stones has led us to all this information here on calcium kidney stones. calcium kidney stones do indeed have a lot to tell!

IT'S NOT PERFECT In trials its success rate in reducing UA levels down to the important 0 mg/dL (357 mmol/??mol) level was not 100%. About 35% of trial patients did not achieve the target. This may have been partly because so many gout sufferers are not UA over-producers, the problem Febuxostat addresses, but under-excretors of uric acid. It was with keen interest that we got about to writing on calcium kidney stones. Hope you read and appreciate it with equal interest.

If you have severe kidney or liver problems Febuxostat is not recommended since it has not been tested in these patient groups. It is not recommended for people with heart disease or children.

NB. The contents of this article contain medical information not medical advice. Please always discuss remedies with your doctor or other health care professional, before implementing any treatment. Aiming high is our motto when writing about any topic. In this way, we tend to add whatever matter there is about calcium kidney stones, rather than drop any topic.

It is recommended that NSAIDs or Colchicine are used along with Adenuric. This is because, as with Allopurinol, on a course of Febuxostat, there may be an initial increase in gout flares. If this happens you must battle through the attacks and continue taking Adenuric. We are satisfied with this end product on calcium kidney stones. It was really worth the hard work and effort in writing so much on calcium kidney stones.

And it may cause side effects of course. See the bottom of this article. Febuxostat (Adenuric) is not unfortunately a treatment for gout pain. It won't be used instead of NSAIDS like Indomethacin, Colchicine, and corticosteroids. It was with great relief we ended writing on calcium kidney stones. There was just too much information to write, that we were starting to lose hopes on it's completion!

WHO WILL BE PRESCRIBED IT? The recommended dose is one 80 mg daily tablet. If after two weeks there is no reduction in UA levels, your doctor may increase the dose to 120 mg daily. Patients will need another serum UA test after two weeks treatment to find out how well it's doing. In trials it has usually worked quickly, within a couple of weeks.

 
Try Goutezol for 60 Days

People Said About Goutezol Gout Treatment
"I've been suffering from gout for over 3 years. I tried many different remedies. After taking your product for 20 days I felt the difference. I'm ordering 3 more bottles to make sure I'm not going to have attack any time soon." Bill, FL
gout treatment


You will not need to be on a low purine diet, and more good news is that it can be prescribed for the elderly. Kidney and liver disease In trials it has performed quite well with patients who have mild kidney disease. 44% of patients achieved the target at an 80 mg dosage, more at higher dosages. Better results than Allopurinol. If you have mild kidney disease (renal impairment) or mild liver problems (hepatic impairment) your doctor will judge whether Adenuric/Febuxostat can be taken safely. Enhancing your vocabulary is our intention with the writing of this article on calcium kidney stones. We have used new and interesting words to achieve this.

Your uric acid levels will have to be high. If you have gout but normal or slightly raised uric acid levels as some do, it is unlikely to be prescribed. We have not included any imaginary or false information on calcium kidney stones here. Everything here is true and up to the mark!

It will also only be used in gout patients who have chronic hyperuricemia (high UA levels) and gout. So if you're a gout sufferer who lives in a European country that's a member of the EU, you can ask your doctor's opinion about whether Febuxostat is suitable for you. Using our imagination has helped us create a wonderful article on calcium kidney stones. Being imaginative is indeed very important when writing about calcium kidney stones!

This approval applies only to EU countries. Febuxostat has not yet been approved in the United States. If you are reading this from a non-EU country, or the US, you can check with your doctor to find out whether, or when, Febuxostat will be approved in your country. Even the beginner will get to learn more about calcium kidney stones after reading this article. It is written in easy language so that everyone will be able to understand it.

At 120 mg it has reduced UA levels to the target of 6.0 mg/dL in over 60% of study patients. At 80 mg the numbers were around 51%. Allopurinol at a 300 mg dosage in most participants achieved this is 22% of study patients. Hence the excited buzz in rheumatology circles since these kinds of results became apparent in its trials. At or below 6.0 mg/dL gout is more likely to be cured or managed better.

Tophi If you have tophi, it's heartening to know that Febuxostat has been shown to have success against tophi. Measured tophi areas reduced in many patients with tophi. The presence of tophi will be an additional factor in favour of a decision to prescribe Febuxostat (Adenuric). Suppressing our knowledge on calcium kidney stones is not our intention here. In fact, we mean to let everyone know more about calcium kidney stones after reading this!

John Mepham has lost track of the number of hours he has spent researching gout treatments. His best tip for curing gout naturally? Get to your ideal weight whatever the sacrifices may be. Learn more about natural gout treatment at www.gout-smashers-guide.com It's an e-book with an emphasis on natural gout treatment


 
 
     
 
 





Learn More about Natural Gout Remedy

A gout diet plan is an important part of controlling your gout symptoms and attacks. After all, when not controlled, gout can cause severe and permanent damage to your tissues, joints, and tendons. As gout is caused by high levels of uric acid in the blood, a proper gout diet plan should aim to reduce uric acid levels and encourage proper elimination of uric acid from the body. There are...


There are many reason that can cause a gout. The main risk factor in a gout case is the levels of uric acid that one has in his/ her body. This increased levels can be cause by many factors, and diet is one of those. Certain types of foods have in their composition purine. These compounds are known to rise the levels of uric acid. In turn, uric acid is what cause a gout. So, if you stop...


Arthritis is the #1 cause of disability in America today, impacting approximately seven million people. It is now one of the most prevalent chronic health problems. The estimated annual costs of arthritis to Americans are $15 billion in direct medical costs and $49 billion in indirect costs such as lost wages. Nearly 40 million Americans have arthritis, with 24 million of them being under 65...


b>Osteoarthritis: Cause and Symptoms In our last article, we briefly discussed Osteoarthritis and Rheumatoid Arthritis. This article will take a close look at the cause, symptoms, and current treatment used for Osteoarthritis. So let's take a second look at what Osteoarthritis is. Osteoarthritis is known by many as "wear and tear" Arthritis. It is one of the most common forms of...


In May 2008 the U.S. based company developing Pegloticase made another upbeat statement assessment of what they have learnt in its Phase 3 and open label extension trials. Note that Pegloticase still awaits approval from medical authorities so I am writing here about a new gout drug that is still under development. May was a good month for gout sufferers. Febuxostat, (EU trade/brand name...


foods that cause gout | what is a purine base | gout and indomethacin | foods uric acid blood | calcium kidney stones | kidney stone dissolve |







 
 
 
 
 
 
 
(c) 2008 www.symptomsofgout.info | RSS Feed | | calcium kidney stones - A New Gout Drug. Febuxostat wins marketing approval in the European Union